# Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

> **NCT02280135** · PHASE1 · COMPLETED · sponsor: **Red de Terapia Celular** · enrollment: 8 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** Intravitreal injection of Autologous bone marrow Stem Cell
- **OTHER:** Subconjunctival injection of saline

## Key facts

- **NCT ID:** NCT02280135
- **Lead sponsor:** Red de Terapia Celular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280135, "Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02280135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*